ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS CURRENT STANDARD OF CARE REGIMEN IN A UNITED STATES NON-VALVULAR ATRIAL FIBRILLATION POPULATION SIMILAR TO THAT ENROLLED IN ARISTOTLE AND AVERROES

✍ Scribed by Phatak, Hemant; Dorian, Paul; Kongnakorn, Thitima; Lanitis, Tereza; Kuznik, Andreas; Mardekian, Jack; Liu, Xianchen; Lawrence, Jack; Lip, Gregory

• Book ID: 122317434
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 237 KB
• Volume: 63
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/S0735-1097(14)60422-8